These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16494416)

  • 1. Binding of novel azole-bridged dinuclear platinum(II) anticancer drugs to DNA: insights from hybrid QM/MM molecular dynamics simulations.
    Magistrato A; Ruggerone P; Spiegel K; Carloni P; Reedijk J
    J Phys Chem B; 2006 Mar; 110(8):3604-13. PubMed ID: 16494416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameterization of azole-bridged dinuclear platinum anticancer drugs via a QM/MM force matching procedure.
    Spiegel K; Magistrato A; Maurer P; Ruggerone P; Rothlisberger U; Carloni P; Reedijk J; Klein ML
    J Comput Chem; 2008 Jan; 29(1):38-49. PubMed ID: 17705162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azole-bridged diplatinum anticancer compounds. Modulating DNA flexibility to escape repair mechanism and avoid cross resistance.
    Spiegel K; Magistrato A; Carloni P; Reedijk J; Klein ML
    J Phys Chem B; 2007 Oct; 111(41):11873-6. PubMed ID: 17927270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
    Deubel DV
    J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding.
    Teletchéa S; Komeda S; Teuben JM; Elizondo-Riojas MA; Reedijk J; Kozelka J
    Chemistry; 2006 May; 12(14):3741-53. PubMed ID: 16514681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
    Komeda S; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Am Chem Soc; 2002 May; 124(17):4738-46. PubMed ID: 11971723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How strong can the bend be on a DNA helix from cisplatin? DFT and MP2 quantum chemical calculations of cisplatin-bridged DNA purine bases.
    Burda JV; Leszczynski J
    Inorg Chem; 2003 Nov; 42(22):7162-72. PubMed ID: 14577785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer.
    McGowan G; Parsons S; Sadler PJ
    Chemistry; 2005 Jul; 11(15):4396-404. PubMed ID: 15880542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
    Baruah H; Wright MW; Bierbach U
    Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination by electrospray mass spectrometry of the outersphere association constants of DNA/platinum complexes using 20-mer oligonucleotides and ([Pt(NH(3))(4)](2+), 2Cl(-)) or ([Pt(py)(4)](2+), 2Cl(-)).
    Carte N; Legendre F; Leize E; Potier N; Reeder F; Chottard JC; Van Dorsselaer A
    Anal Biochem; 2000 Aug; 284(1):77-86. PubMed ID: 10933859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neglected bidentate sp2 N-donor carrier ligands with triazine nitrogen lone pairs: platinum complexes retromodeling cisplatin guanine nucleobase adducts.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2008 Oct; 47(20):9303-13. PubMed ID: 18800828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure, and reactivity of monofunctional platinum(II) and palladium(II) complexes containing the sterically hindered ligand 6-(methylpyridin-2-yl)acetate.
    Ma Y; Day CS; Bierbach U
    J Inorg Biochem; 2005 Oct; 99(10):2013-23. PubMed ID: 16087242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
    Spiegel K; Magistrato A
    Org Biomol Chem; 2006 Jul; 4(13):2507-17. PubMed ID: 16791311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
    Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
    Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computational study on DNA bases interactions with dinuclear tetraacetato-diaqua-dirhodium(II,II) complex.
    Burda JV; Gu J
    J Inorg Biochem; 2008 Jan; 102(1):53-62. PubMed ID: 17698203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA structural distortions induced by ruthenium-arene anticancer compounds.
    Gossens C; Tavernelli I; Rothlisberger U
    J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-links of quadruplex structures from human telomeric DNA by dinuclear platinum complexes show the flexibility of both structures.
    Ourliac-Garnier I; Elizondo-Riojas MA; Redon S; Farrell NP; Bombard S
    Biochemistry; 2005 Aug; 44(31):10620-34. PubMed ID: 16060671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.